Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Focusing on anti-dsDNA antibodies, the criteria stated a specification of ‘an abnormal anti-native DNA titer’ but they did not recommend any assay stringency or quality.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“The first classification criteria for SLE were formulated in 1971 by the American College of Rheumatology (ACR), followed by two revisions in 1982 and 1997.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“Both the 1971 and the revised 1982 criteria, further updated in 1997 by the ACR (formerly ARA) [17], required at least 4 of the 11 criteria for SLE classification to be present serially or simultaneously.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“For detection of anti-dsDNA antibodies only limited requirements for test characteristics were defined, varying from ‘increased titer’ [16,17], ‘above laboratory reference range (except for ELISA)’ [18], to ‘>90% specificity’ [19].”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“SLE was diagnosed and classified based on either the revised American College of Rheumatology10 or the Systemic Lupus International Collaborating Clinics classification criteria.11”
From Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus (2020) · cites this paper as [10]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164
Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993
The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features
ASHERSON, R. A., KHAMASHTA, M. A., ORDI-ROS, J., DERKSEN, R. H. W. M., MACHIN, S. J., BARQUINERO, J., OUTT, H. H., HARRIS, E. N., VILARDELL-TORRES, M., & HUGHES, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 959
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Harris, E. N., Gharavi, A. E., Patel, S., & Hughes, G. R. (1987) · PubMed Central · Cited by 795
ALARCÓN-SEGOVIA, D., DELEZÉ, M., ORIA, C. V., SÁNCHEZ-GUERRERO, J., GÓMEZ-PACHECO, L., CABIEDES, J., FERNÁNDEZ, L., & DE LEÓN, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 639
Harris, E. N. (1990) · American Journal of Clinical Pathology · doi:10.1093/ajcp/94.4.476 · Cited by 414
Exner, T., Triplett, D. A., Taberner, D. A., & Machin, S. J. (1991) · PubMed · Cited by 243
Cited by
Items 201–300 of 329
McMahon, M., Grossman, J., Skaggs, B., FitzGerald, J., Sahakian, L., Ragavendra, N., Charles‐Schoeman, C., Watson, K., Wong, W. K., Volkmann, E., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24677 · Cited by 216
Arnaud, L., Mathian, A., Ruffatti, A., Erkan, D., Tektonidou, M., Cervera, R., Forastiero, R., Pengo, V., Lambert, M., Martinez-Zamora, M. A., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.014 · Cited by 215
Moreth, K., Brodbeck, R., Babelova, A., Gretz, N., Spieker, T., Zeng-Brouwers, J., Pfeilschifter, J., Young, M. F., Schaefer, R. M., & Schaefer, L. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42213 · Cited by 207
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
Ünlü, O., Zuily, S., & Erkan, D. (2019) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2015.0085 · Cited by 207
Sciascia, S., Hunt, B. J., Talavera-Garcia, E., Lliso, G., Khamashta, M. A., & Cuadrado, M. J. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.09.078 · Cited by 201
The antiphospholipid syndrome in patients with systemic lupus erythematosus
Pons-Estel, G. J., Andreoli, L., Scanzi, F., Cervera, R., & Tincani, A. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.10.004 · Cited by 201
“Even thought we have classification criteria for SLE and APS, attributing clinical manifestations to SLE or to primary APS can be difficult, since primary APS may present with proteinuria, pleurisy in the setting of a pulmonary embolus, seizures, psychosis, hemolytic anemia and thrombocytopenia being all these manifes…”
BackgroundLeuchten, N., Hoyer, A., Brinks, R., Schoels, M., Schneider, M., Smolen, J., Johnson, S. R., Daikh, D., Dörner, T., Aringer, M., et al. (2018) · Arthritis Care & Research · doi:10.1002/acr.23292 · Cited by 190
Caza, T. N., Fernandez, D. R., Talaber, G., Oaks, Z., Haas, M., Madaio, M. P., Lai, Z.-W., Miklossy, G., Singh, R. R., Chudakov, D. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203794 · Cited by 193
Terrier, B., Derian, N., Schoindre, Y., Chaara, W., Geri, G., Zahr, N., Mariampillai, K., Rosenzwajg, M., Carpentier, W., Musset, L., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4060 · Cited by 193
“when they met at least four of the 1997 American College of Rheumatology criteria for SLE [15].”
BackgroundUrowitz, M. B., Gladman, D. D., Ibañez, D., Fortin, P. R., Bae, S. C., Gordon, C., Clarke, A., Bernatsky, S., Hanly, J. G., Isenberg, D., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.20648 · Cited by 191
Perl, A., Hanczko, R., Lai, Z.-W., Oaks, Z., Kelly, R., Borsuk, R., Asara, J. M., & Phillips, P. E. (2015) · Metabolomics · doi:10.1007/s11306-015-0772-0 · Cited by 189
Andrade, R. M., Alarcón, G. S., Fernández, M., Apte, M., Vilá, L. M., & Reveille, J. D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22375 · Cited by 184
McBride, J. M., Jiang, J., Abbas, A. R., Morimoto, A., Li, J., Maciuca, R., Townsend, M., Wallace, D. J., Kennedy, W. P., & Drappa, J. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34632 · Cited by 186
Lessard, C. J., Adrianto, I., Ice, J. A., Wiley, G. B., Kelly, J. A., Glenn, S. B., Adler, A. J., Li, H., Rasmussen, A., Williams, A. H., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.02.023 · Cited by 185
Petri, M. A., van Vollenhoven, R. F., Buyon, J., Levy, R. A., Navarra, S. V., Cervera, R., Zhong, Z. J., Freimuth, W. W., & Groups, O. B. O. T. B. A. B. S. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37995 · Cited by 181
High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis
Trendelenburg, M., Lopez-Trascasa, M., Potlukova, E., Moll, S., Regenass, S., Fremeaux-Bacchi, V., Martinez-Ara, J., Jancova, E., Picazo, M. L., Honsova, E., et al. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl436 · Cited by 180
Kozora, E., Ellison, M. C., & West, S. (2006) · Arthritis Care & Research · doi:10.1002/art.22101 · Cited by 179
Pontillo, A., Girardelli, M., Kamada, A. J., Pancotto, J. A. T., Donadi, E. A., Crovella, S., & Sandrin-Garcia, P. (2012) · Autoimmunity · doi:10.3109/08916934.2011.637532 · Cited by 178
“The SLE subgroups clinical classification (SLERD, SLE-ND, SLE-RD-ND) as well as the presence of some peculiar manifestation possibly related to inflammasome dysfunction (rash, arthritis, neurological impairment) [5] were then considered.”
BackgroundMethodCoenen, D., Verschueren, P., Westhovens, R., & Bossuyt, X. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.078063 · Cited by 175
“org/content/vol53/issue3). Diagnoses of the diseased controls were established as follows: psoriatic arthritis on the basis of a typical psoriasiform presentation of the arthritis, systemic lupus erythematosus (SLE) according to the revised ACR criteria ( 16 ), Sjo¨gren syndrome according to the proposed European clas…”
BackgroundHo Lee, Y., Witte, T., Momot, T., Schmidt, R. E., Kaufman, K. M., Harley, J. B., & Sestak, A. L. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21484 · Cited by 173
The Clinical Utility of a Positive Antinuclear Antibody Test Result
Abeles, A. M., & Abeles, M. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.09.014 · Cited by 173
de Rycke, L., Baeten, D., Kruithof, E., Van den Bosch, F., Veys, E. M., & de Keyser, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21190 · Cited by 172
“Although more than 40 cases of TNF blockade–related lupus-like syndromes have been reported, the present data provide evidence that ANAs and anti-dsDNA antibodies as well as mild hematologic abnormalities can hardly be considered as lupus criteria in this context, and confirm that clinically relevant lupus erythematos…”
BackgroundMethodSun, L., Zhang, H., Feng, X., Hou, Y., Lu, L., & Fan, L. (2007) · Lupus · doi:10.1177/0961203306075793 · Cited by 172
Lee, J., Wang, L., Lin, Y., Yang, Y., Lin, D., & Chiang, B. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02306.x · Cited by 172
Increased levels of KL‐6 and subsequent mortality in patients with interstitial lung diseases
SATOH, H., KURISHIMA, K., ISHIKAWA, H., & OHTSUKA, M. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01704.x · Cited by 171
Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity
Ruffatti, A., Tonello, M., Del Ross, T., Cavazzana, A., Grava, C., Noventa, F., Tona, F., Iliceto, S., & Pengo, V. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-05-0287 · Cited by 170
Christophersen, A., Lund, E. G., Snir, O., Solà, E., Kanduri, C., Dahal-Koirala, S., Zühlke, S., Molberg, Ø., Utz, P. J., Rohani-Pichavant, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0403-9 · Cited by 164
Yuan, X., Qin, X., Wang, D., Zhang, Z., Tang, X., Gao, X., Chen, W., & Sun, L. (2019) · Nature Communications · doi:10.1038/s41467-019-10491-8 · Cited by 164
Maternal and foetal outcomes in pregnant patients with active lupus nephritis
Wagner, S., Craici, I., Reed, D., Norby, S., Bailey, K., Wiste, H., Wood, C., Moder, K., Liang, K., Liang, K., et al. (2009) · Lupus · doi:10.1177/0961203308097575 · Cited by 163
Tam, L., Chan, A. Y. K., Chan, P. K. S., Chang, A. R., & Li, E. K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20616 · Cited by 162
Arnaud, L., Mathian, A., Devilliers, H., Ruffatti, A., Tektonidou, M., Forastiero, R., Pengo, V., Lambert, M., Lefevre, G., Martinez-Zamora, M. A., et al. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.019 · Cited by 146
“Finally, the 13th aPL task force recommends prophylaxis with low-dose aspirin in SLE patients with LA positivity or isolated persistently positive aCL at medium-high titers, and in non-SLE patients with LA positivity or triple positivity or isolated persistently positive aCL at medium-high titers [5].”
MethodInfluentialYang, Z., Zhang, Z., Lin, F., Ren, Y., Liu, D., Zhong, R., & Liang, Y. (2017) · APMIS · doi:10.1111/apm.12722 · Cited by 145
Oaks, Z., Winans, T., Caza, T., Fernandez, D., Liu, Y., Landas, S. K., Banki, K., & Perl, A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39791 · Cited by 136
Barcellos, L. F., May, S. L., Ramsay, P. P., Quach, H. L., Lane, J. A., Nititham, J., Noble, J. A., Taylor, K. E., Quach, D. L., Chung, S. A., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000696 · Cited by 131
Gonad evaluation in male systemic lupus erythematosus
Soares, P. M. F., Borba, E. F., Bonfa, E., Hallak, J., Corrêa, A. L., & Silva, C. A. A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22660 · Cited by 130
Manson, J. J., Ma, A., Rogers, P., Mason, L. J., Berden, J. H., van der Vlag, J., D'Cruz, D. P., Isenberg, D. A., & Rahman, A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2831 · Cited by 129
Ho, K. T., Ahn, C. W., Alarcón, G. S., Baethge, B. A., Tan, F. K., Roseman, J., Bastian, H. M., Fessler, B. J., McGwin, G., Vilá, L. M., et al. (2005) · Rheumatology · doi:10.1093/rheumatology/kei014 · Cited by 128
“The LUMINA (Lupus in Minorities: Nature versus Nurture) cohort consists of SLE patients with disease duration of 5 yr enrolled in a longitudinal study of outcome from three geographical areas and four institutions in the USA.”
BackgroundInfluentialPlatelets release mitochondrial antigens in systemic lupus erythematosus
Melki, I., Allaeys, I., Tessandier, N., Lévesque, T., Cloutier, N., Laroche, A., Vernoux, N., Becker, Y., Benk-Fortin, H., Zufferey, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aav5928 · Cited by 125
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome
Muratori, P., Granito, A., Pappas, G., Pendino, G. M., Quarneti, C., Cicola, R., Menichella, R., Ferri, S., Cassani, F., Bianchi, F. B., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.126 · Cited by 125
“Anti-dsDNA alone is not specific of the OS disease, given its high sensitivity in systemic lupus erythematosus and its frequent occurrence in classical type 1 AIH (”
BackgroundHarboe, E., Tjensvoll, A. B., Maroni, S., Gøransson, L. G., Greve, O. J., Beyer, M. K., Herigstad, A., Kvaløy, J. T., & Omdal, R. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.098301 · Cited by 124
“Medical records were reviewed of all inpatients and outpatients diagnosed as having SLE between 1980 and 2004 at Stavanger University Hospital, Norway. In all, 86 patients, all Caucasians, fulfilled the revised ACR criteria for SLE.”
MethodZhao, M., Tan, Y., Peng, Q., Huang, C., Guo, Y., Liang, G., Zhu, B., Huang, Y., Liu, A., Wang, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02890-0 · Cited by 122
Systemic lupus erythematosus diagnosis and management
Thong, B., & Olsen, N. J. (2016) · Rheumatology · doi:10.1093/rheumatology/kew401 · Cited by 120
Depression and Cognitive Impairment in Newly Diagnosed Systemic Lupus Erythematosus
PETRI, M., NAQIBUDDIN, M., CARSON, K. A., WALLACE, D. J., WEISMAN, M. H., HOLLIDAY, S. L., SAMPEDRO, M., PADILLA, P. A., & BREY, R. L. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091366 · Cited by 117
Tedeschi, S. K., Johnson, S. R., Boumpas, D., Daikh, D., Dörner, T., Jayne, D., Kamen, D., Lerstrøm, K., Mosca, M., Ramsey‐Goldman, R., et al. (2018) · Arthritis Care & Research · doi:10.1002/acr.23317 · Cited by 112
“The 1982 American College of Rheumatology (ACR) classification criteria for systemic lupus erythematosus (SLE) (1) and their 1997 revision (2) have shaped our understanding of SLE and have been used widely in lupus research for decades.”
BackgroundMethodHarris, H. R., Costenbader, K. H., Mu, F., Kvaskoff, M., Malspeis, S., Karlson, E. W., & Missmer, S. A. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207704 · Cited by 112
Kravvariti, E., Koutsogianni, A., Samoli, E., Sfikakis, P. P., & Tektonidou, M. G. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102491 · Cited by 115
Complement as a Biomarker for Systemic Lupus Erythematosus
Ayano, M., & Horiuchi, T. (2023) · Biomolecules · doi:10.3390/biom13020367 · Cited by 100
The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
Piga, M., & Arnaud, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020243 · Cited by 99
“Nonetheless, a recent single-center retrospective study suggested that 7–17% of patients diagnosed as having early SLE are not correctly classified using the EULAR/ACR 2019 [9], SLICC 2012 [10] and ACR 1982/1997 [11] criteria individually, while the combined use of all three sets of criteria ensured the classification…”
BackgroundToward new criteria for systemic lupus erythematosus-a standpoint
Aringer, M., Dörner, T., Leuchten, N., & Johnson, S. R. (2016) · Lupus · doi:10.1177/0961203316644338 · Cited by 93
Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases
Meroni, P. L., Biggioggero, M., Pierangeli, S. S., Sheldon, J., Zegers, I., & Borghi, M. O. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.180 · Cited by 92
Ramos-Casals, M., Campoamor, M. T., Chamorro, A., Salvador, G., Segura, S., Botero, J. C., Yagüe, J., Cervera, R., Ingelmo, M., & Font, J. (2004) · Lupus · doi:10.1191/0961203304lu1080oa · Cited by 91
HLA associations and HLA sharing in recurrent miscarriage: A systematic review and meta-analysis
Meuleman, T., Lashley, L. E. L. O., Dekkers, O. M., van Lith, J. M. M., Claas, F. H. J., & Bloemenkamp, K. W. M. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.02.004 · Cited by 89
Choi, M. Y., Chen, I., Clarke, A. E., Fritzler, M. J., Buhler, K. A., Urowitz, M., Hanly, J., St-Pierre, Y., Gordon, C., Bae, S.-C., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223808 · Cited by 89
“Between 1999 and 2011, 1827 patients fulfilling the 1997 Updated ACR SLE Classification Criteria for definite SLE 19 within 15 months of diagnosis from 31 medical centres in 11 countries were enrolled into the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort…”
MethodTarr, T., Lakos, G., Bhattoa, H. P., Shoenfeld, Y., Szegedi, G., & Kiss, E. (2007) · Lupus · doi:10.1177/0961203306074767 · Cited by 88
Mummert, E., Fritzler, M. J., Sjöwall, C., Bentow, C., & Mahler, M. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.05.014 · Cited by 86
Wichainun, R. (2013) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap0272.31.4.2013 · Cited by 82
MEHRANI, T., & PETRI, M. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100568 · Cited by 79
Martinez-Berriotxoa, A., Ruiz-Irastorza, G., Egurbide, M.-V., Garmendia, M., Gabriel Erdozain, J., Villar, I., & Aguirre, C. (2007) · Lupus · doi:10.1177/0961203307083316 · Cited by 76
Testicular Sertoli cell function in male systemic lupus erythematosus
Suehiro, R. M., Borba, E. F., Bonfa, E., Okay, T. S., Cocuzza, M., Soares, P. M. F., & Silva, C. A. A. (2008) · Rheumatology · doi:10.1093/rheumatology/ken338 · Cited by 76
Becker, Y., Loignon, R.-C., Julien, A.-S., Marcoux, G., Allaeys, I., Lévesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., Melki, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40900-3 · Cited by 75
Yelnik, C. M., Urbanski, G., Drumez, E., Sobanski, V, Maillard, H., Lanteri, A., Morell-Dubois, S., Caron, C., Dubucquoi, S., Launay, D., et al. (2017) · Lupus · doi:10.1177/0961203316657433 · Cited by 73
Gebhart, J., Posch, F., Koder, S., Perkmann, T., Quehenberger, P., Zoghlami, C., Ay, C., & Pabinger, I. (2015) · Blood · doi:10.1182/blood-2014-11-611129 · Cited by 77
Antico, A., Platzgummer, S., Bassetti, D., Bizzaro, N., Tozzoli, R., Villalta, D., & Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine (SIMeL) (2010) · Lupus · doi:10.1177/0961203310362995 · Cited by 70
Davies, R., Lomer, M., Yeo, S., Avloniti, K., Sangle, Sr., & D’Cruz, D. (2012) · Lupus · doi:10.1177/0961203312436854 · Cited by 70
TGF-β and Eomes control the homeostasis of CD8+ regulatory T cells
Mishra, S., Liao, W., Liu, Y., Yang, M., Ma, C., Wu, H., Zhao, M., Zhang, X., Qiu, Y., Lu, Q., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200030 · Cited by 69
“All SLE patients fulfilled at least four of the SLE classification criteria of the American College of Rheumatology (Hochberg, 1997).”
BackgroundMethodAringer, M., Brinks, R., Dörner, T., Daikh, D., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219373 · Cited by 68
Erkan, D., Unlu, O., Sciascia, S., Belmont, H. M., Branch, D. W., Cuadrado, M. J., Gonzalez, E., Knight, J. S., Uthman, I., Willis, R., et al. (2018) · Lupus · doi:10.1177/0961203317724219 · Cited by 66
Schmajuk, G., Hoyer, B. F., Aringer, M., Johnson, S. R., Daikh, D. I., Dörner, T., & the SLE classification criteria steering committee and the international SLE expert panel of the initiative (2018) · Arthritis Care & Research · doi:10.1002/acr.23503 · Cited by 65
Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA
Becker, Y., Marcoux, G., Allaeys, I., Julien, A.-S., Loignon, R.-C., Benk-Fortin, H., Rollet-Labelle, E., Rauch, J., Fortin, P. R., & Boilard, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01026 · Cited by 59
“Patients with SLE met the 1982 ACR classification criteria for SLE (revised in 1997) (44, 45).”
BackgroundMethodReduced cerebrospinal fluid BACE1 activity in multiple sclerosis
Mattsson, N., Axelsson, M., Haghighi, S., Malmeström, C., Wu, G., Anckarsäter, R., Sankaranarayanan, S., Andreasson, U., Fredrikson, S., Gundersen, A., et al. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458508100031 · Cited by 61
Del Ross, T., Ruffatti, A., Visentin, M. S., Tonello, M., Calligaro, A., Favaro, M., Hoxha, A., & Punzi, L. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.120576 · Cited by 60
Hikami, K., Kawasaki, A., Ito, I., Koga, M., Ito, S., Hayashi, T., Matsumoto, I., Tsutsumi, A., Kusaoi, M., Takasaki, Y., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30188 · Cited by 58
Sweiss, N. J., Bo, R., Kapadia, R., Manst, D., Mahmood, F., Adhikari, T., Volkov, S., Badaracco, M., Smaron, M., Chang, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012280 · Cited by 56
“As patients in our study were positive for IgA anti-b2GPI, but negative for all other aPL, SLE status was unchanged by application of the revised ACR criteria, which include aPL positivity [20].”
Fischer-Betz, R., Specker, C., Brinks, R., & Schneider, M. (2012) · Lupus · doi:10.1177/0961203312451335 · Cited by 56
Yelnik, C. M., Porter, T. F., Branch, D. W., Laskin, C. A., Merrill, J. T., Guerra, M. M., Lockshin, M. D., Buyon, J. P., Petri, M., Sammaritano, L. R., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39668 · Cited by 54
Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models
Ceccarelli, F., Sciandrone, M., Perricone, C., Galvan, G., Morelli, F., Vicente, L. N., Leccese, I., Massaro, L., Cipriano, E., Spinelli, F. R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174200 · Cited by 53
Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus
Deng, Y. J., Huang, Z. X., Zhou, C. J., Wang, J. W., You, Y., Song, Z. Q., Xiang, M. M., Zhong, B. Y., & Hao, F. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.039 · Cited by 51
Lee, H.-T., Lin, C.-S., Chen, W.-S., Liao, H.-T., Tsai, C.-Y., & Wei, Y.-H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078853 · Cited by 49
“According to the American College of Rheumatology criteria for the classification of SLE [31,32], a total of 85 SLE patients (73 females) with a mean age of 44.”
MethodMEHRANI, T., & PETRI, M. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100650 · Cited by 49
Li, T., Prokopec, S. D., Morrison, S., Lou, W., Reich, H., Gladman, D., Urowitz, M., Scholey, J., Fortin, P. R., Boutros, P. C., et al. (2015) · Rheumatology · doi:10.1093/rheumatology/keu326 · Cited by 49
Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients
Morgan, P. E., Sturgess, A. D., & Davies, M. J. (2009) · Free Radical Research · doi:10.1080/10715760802623896 · Cited by 48
Amano, M. T., Ferriani, V. P. L., Florido, M. P. C., Reis, E. S., Delcolli, M. I. M. V., Azzolini, A. E. C. S., Assis-Pandochi, A. I., Sjöholm, A. G., Farah, C. S., Jensenius, J. C., et al. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.09.034 · Cited by 48
Does the anti-β2-glycoprotein I antibody provide additional information in patients with thrombosis?
Lee, E. Y., Lee, C.-K., Lee, T. H., Chung, S. M., Kim, S. H., Cho, Y. S., Yoo, B., & Moon, H.-B. (2003) · Thrombosis Research · doi:10.1016/j.thromres.2003.08.023 · Cited by 47
Fatigue in systemic lupus erythematosus: An association with reduced physical fitness
Balsamo, S., & Santos-Neto, L. D. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.03.005 · Cited by 47
Villalta, D., Romelli, P. B., Savina, C., Bizzaro, N., Tozzoli, R., Tonutti, E., Ghirardello, A., & Doria, A. (2003) · Lupus · doi:10.1191/0961203303lu277oa · Cited by 45
SWADŹBA, J., IWANIEC, T., SZCZEKLIK, A., & MUSIAŁ, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02669.x · Cited by 44
Facciotti, F., Gagliani, N., Häringer, B., Alfen, J. S., Penatti, A., Maglie, S., Paroni, M., Iseppon, A., Moro, M., Crosti, M. C., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.06.044 · Cited by 43
Jaekel, H.-P., Trabandt, A., Grobe, N., & Werle, E. (2006) · Lupus · doi:10.1191/0961203306lu2308oa · Cited by 43
Zhang, J., Jacobi, A. M., Wang, T., & Diamond, B. (2008) · Molecular Medicine · doi:10.2119/2008-00066.zhang · Cited by 43
Rekvig, O. P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.569234 · Cited by 42
“One basic problem is that the SLE study objects—the patients— are included based on selected heterogeneous clusters of classification criteria as defined in the 1982 ACR (1), the 1997 revised ACR (4), the 2012 SLICC criteria (2) and recently the 2019 EULAR/ACR classification criteria for SLE (5) instead of selecting c…”
BackgroundInfluentialCOPPLE, S. S., MARTINS, T. B., MASTERSON, C., JOLY, E., & HILL, H. R. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.052 · Cited by 42
Wang, C.-R., & Liu, M.-F. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.02.002 · Cited by 41
Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus
Infantino, M., Nagy, E., Bizzaro, N., Fischer, K., Bossuyt, X., & Damoiseaux, J. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100139 · Cited by 38
“In 1979, ARA proposed examining new potential serologic criteria in order to update the 1971 criteria.”
BackgroundMethodInfluentialHsu, C.-Y., Lin, Y.-S., Su, Y.-J., Lin, H.-F., Lin, M.-S., Syu, Y.-J., Cheng, T.-T., Yu, S.-F., Chen, J.-F., & Chen, T.-H. (2017) · Rheumatology · doi:10.1093/rheumatology/kex357 · Cited by 38
Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea
Silva, C. A., Deen, M. E. J., Febrônio, M. V., Oliveira, S. K., Terreri, M. T., Sacchetti, S. B., Sztajnbok, F. R., Marini, R., Quintero, M. V., Bica, B. E., et al. (2011) · Rheumatology International · doi:10.1007/s00296-010-1389-2 · Cited by 38
(2014) · PubMed · Cited by 38
P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus
Furini, F., Giuliani, A. L., Parlati, M. E., Govoni, M., Di Virgilio, F., & Bortoluzzi, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00435 · Cited by 37
“Patients with SLE satisfying the 1997 revised American College of Rheumatology criteria (Hochberg, 1997), were recruited consecutively from the Rheumatology Unit, S. Anna Hospital, University of Ferrara.”
MethodHuang, H., Liu, X., Chen, D., Lu, Y., Li, J., Du, F., Zhang, C., & Lu, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106365 · Cited by 36
Launay, D., Schmidt, J., Lepers, S., Mirault, T., Lambert, M., Kyndt, X., Reumaux, D., Duhamel, A., Hachulla, E., Hatron, P.-Y., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.03.016 · Cited by 35
Hayashi, A. P., Solis, M. Y., Sapienza, M. T., Otaduy, M. C. G., de Sá Pinto, A. L., Silva, C. A., Sallum, A. M. E., Pereira, R. M. R., & Gualano, B. (2014) · Lupus · doi:10.1177/0961203314546017 · Cited by 35
Metadata
- Authors
- Hochberg, M. C.
- Affiliations
- American College of Rheumatology (US)
- Corresponding author
- Hochberg, Marc C.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1997-09
- Volume
- 40
- Issue
- 9
- Pages
- 1725-1725
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2070527591
- Cited by
- 11,409
- References
- 13
- Citations by year
- 2026: 283 · 2025: 422 · 2024: 515 · 2023: 530 · 2022: 652 · 2021: 701 · 2020: 616 · 2019: 631 · 2018: 634 · 2017: 675 · 2016: 621 · 2015: 633 · 2014: 625 · 2013: 563 · 2012: 490
- FWCI
- 18.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, classification criteria, American College of Rheumatology, disease classification, lupus diagnosis
- MeSH terms
- Diagnosis, Differential, Humans, Lupus Erythematosus, Systemic, Rheumatology, Societies, Medical, United States, Antibodies, Antiphospholipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.